Therapeutic selective adsorption of anti-DNA antibody using dextran sulfate cellulose column (Selesorb) for the treatment of systemic lupus erythematosus

Therapeutic Apheresis

Volumn 2, Issue 1, 1998, Pages 18-24

  Kutsuki, Hidetoshi ^a   Takata, Satoshi ^a   Yamamoto, Kozo ^a   Tani, Nobutaka ^a  

^a KANEKA CORPORATION   (Japan)

Author keywords

Anti DNA antibody; Dextran sulfate cellulose column; Selesorb; Systemic lupus erythematosus

Indexed keywords

BRADYKININ; CARDIOLIPIN ANTIBODY; CELLULOSE; CYCLOPHOSPHAMIDE; DEXTRAN SULFATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA ANTIBODY; PREDNISOLONE; SORBENT;

ADSORPTION; ANAPHYLAXIS; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; APHERESIS; ARTHRALGIA; AUTOMATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG CONTRAINDICATION; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTOPENIA; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RASH; REVIEW; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; VOMITING;

EID: 0031834450     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1998.tb00068.x     Document Type: Review

References (23)

1. Terman DS, Buffaloe G, Mattioli C, Cook G, Tillquist R, Sullivan M, Ayus JC. Extracorporeal immunoadsorption: Initial experience in human systemic lupus erythematosus. Lancet 1979;2(8147):824-7.
2. Fukuma N, Nihei N. Immunoadsorption. Autoantibody. With special reference to SLE. Immunohaematology 1985;7:443-7.
3. Schneider M, Berning T, Waldendorf M, Glaser J, Gerlach U. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus. J Rheumatol 1990;17:900-7.
4. Kinoshita M, Aotsuka S, Funahashi T, Tani N, Yokohari R. Selective removal of anti-double-stranded DNA antibodies by immunoadsorption with dextran sulphate in patients with systemic lupus erythematosus. Ann Rheum Dis 1989;48: 856-60.
5. Tsuda Y, Taniguchi O, Mokuno C, Kawanishi T, Toumyou M, Fujita S, Yokoyama M, Hashimoto H, Hirose S. Trial adsorption of anti-cardiolipin and its application. Jpn J Artif Organs 1989;18:7-10.
6. Aotsuka S, Funahashi T, Tani N, Okawa-Takatsuji M, Kinoshita M, Yokohari R. Adsorption of anti-dsDNA antibodies by immobilized polyanionic compounds. Clin Exp Immunol 1990;79:215-20.
7. Hashimoto H, Tsuda H, Kanai Y, Kobayashi S, Hirose S, Shinoura H, Yokohari R, Kinoshita M, Aotsuka S, Yamada H, Takahashi K, Yoshinoya S, Miyamoto T. Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus. J Rheumatol 1991;18:545-51.
8. Suzuki K, Tanaka N, Matsuki Y, Kawakami M, Kawaguchi Y, Hidaka T, Kawagoe M, Nakamura H. Simplified blood access method for immunoadsorption. J Clin Apheresis 1992;7:97.
9. Matsuki Y, Suzuki K, Kawakami M, Ishizuka T, Kawaguchi Y, Hidaka T, Nakamura H. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns. J Clin Apheresis 1996;11:30-5.
10. Xie J, Munakata Y, Hatakeyama A, Murai C, Shibata S, Ishii T, Sasaki T, Abe K, Kawamura M. Relationship between anti-DNA antibodies determined at the increased ionic strength condition and lupus nephritis. Clin Immunol 1993;25:1672-8.
11. Suzuki N, Harada T, Mizushima Y, Sakane T. Possible pathogenic role of cationic ant-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J Immunol 1993;151:1128-36.
12. Suzuki N, Otuka I, Harada T, Mizushima Y, Sakane T. Preferential adsorption of cationic anti-DNA antibodies with immobilized polyanionic compounds, dextran sulfate. Autoimmunity 1994;19:105-12.
13. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol 1985;62: 738-45.
14. Koike T, Suzuki T, Mukai M, Sagawa A, Ikeda Y, Yamamoto M, Hashimoto H, Aoki K, Nagasawa K. Fundamental and clinical evaluation of anticardiolipin kit "Yamasa" EIA. J Med Pharm Sci 1991;26:535-13.
15. Daimon S, Kakuda S, Arikawa K, Nomura H, Kawano M, Koni I, Takeda R. A case of lupus nephritis improved by immunoadsorption therapy for anti-DNA antibody (in Japanese). Proceedings of the 36th Japan Rheumatism Association 1992:262.
16. Ogawa H, Ono M, Hisanaga S, Kato S, Saito A, Matsumoto Y, Yamamoto K. A case of severe anti-phospholipid antibody syndrome treated by immunoadsorption therapy (in Japanese). Proceedings of the 14th Annual Meeting of the Japanese Society for Apheresis 1994:64.
17. Hashimoto H. Apheresis therapy of systemic lupus erythematosus (in Japanese). Nippon Naika Gakkai Zasshi 1990;79: 1381-6.
18. Suzuki K, Hara M, Harigai M, Ishizuka T, Hirose T, Matsuki Y, Kawaguchi Y, Kitani A, Kawagoe M, Nakamura H. Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus. Arthritis Rheum 1991;34:1546-52.
19. Ishizuka T, Suzuki K, Hara M, Hirose T, Harigai M, Hidaka T, Kawagoe M, Nakamura H. Clinical and immunological evaluation of extracorporeal immunoadsorption therapy for anti-DNA antibodies in patients with systemic lupus erythematosus. Jpn J Clin Immunol 1991;14:267-75.
20. Funauchi M, Imada A, Horiuchi A, Kurata N, Ota Z, Kon'I I, Matsumoto M. Effect of immunoadsorption therapy in systemic lupus erythematosus. Jpn J Apheresis 1997;16:192-3.
21. Tokuda M, Inoh M, Akashi Y, Seto K, Kurata N, Takahara J. Randomized open trial to elucidate the effect of immunoadsorption of anti-DNA antibodies in SLE patients. Jpn J Apheresis 1997;16:183-4.
22. Olbricht CJ, Schaumann D, Fischer D. Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors. Lancet 1992;340:908-9.
23. Tomita M, Shirai S, Soejima K, Watanabe S, Soejima H. IMPP with dextran sulfate columns might remove coagulation factors besides auto-antibody (in Japanese). Jpn Soc Dial Ther 1997;30(Suppl. 1):713.